LU Q41 (Fenofibric Acid Delayed-Release 45 mg)
Pill with imprint LU Q41 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 45 mg. It is supplied by Lupin Pharmaceuticals, Inc.
Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 45 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LU Q41
Fenofibric Acid Delayed-Release
- Imprint
- LU Q41
- Strength
- 45 mg
- Color
- Brown & Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68180-0128
- Inactive Ingredients
-
silicon dioxide,
dibutyl sebacate,
ethylcellulose,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
gelatin,
hypromelloses,
lactose monohydrate,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
potassium hydroxide,
povidone k90,
propylene glycol,
shellac,
sodium lauryl sulfate,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
More about fenofibric acid
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (25)
- Drug images
- Pricing & coupons
- En español
- Drug class: fibric acid derivatives
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.